Earnings Releases·Nov 5, 2026, 6:12 AM ET

Ingredion Incorporated — Third Quarter 2026 Earnings Summary

Third-quarter net sales declined 1% to $1,792 million (up 2% excluding Pakistan), while reported and adjusted operating income fell 19% to $201 million and $206 million respectively, driven by higher input costs, consumer softness, and the Argo facility recovery delay.
Full-year 2026 diluted EPS guidance was lowered to $8.04–$8.49 (reported) and $9.25–$9.70 (adjusted), with net sales expected flat and operating income projected to decline low double digits (reported) to mid-teens (adjusted).
The pending acquisition of Tate & Lyle remains a key strategic focus, with management citing integration planning and future growth opportunities for 2027, though risks regarding integration challenges and potential deal failure persist.
Capital return initiatives continued with a dividend increase to $0.83 per share (12th consecutive year) and $85 million in share repurchases year-to-date, while total debt remained stable at $1.8 billion.
Segment performance was mixed: Texture & Healthful Solutions saw volume growth driven by clean label demand, whereas Food & Industrial Ingredients–U.S./CAN operating income dropped 36% due to Argo facility costs, and All Other results reflected the Pakistan business sale.